Peri-implantitis Market Players:
- Aetna Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc.
- Cadila Pharmaceuticals Limited
- R N Laboratories Pvt Ltd
- Neoss Limited
- Basic Pharma Lifesciences Pvt Ltd
- Dawood and Tanner
- Prachi Pharmaceuticals Private Limited
- Geistlich Pharma AG.
- Healthy Life Pharma Private Limited.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of peri-implantitis is assessed at USD 1.25 billion.
The global peri-implantitis market size was valued at more than USD 1.16 billion in 2025 and is expected to register a CAGR of over 9%, exceeding USD 2.75 billion revenue by 2035.
The peri-implantitis market in Asia Pacific is projected to dominate the largest revenue share by 2035, owing to the rising prevalence of oral diseases and increasing awareness regarding oral health across the region.
Key players in the market include Johnson Controls International plc, ABB Ltd., Schneider Electric SE, Emerson Electric Co., Advanced Control Systems, LLC, Hitachi, Ltd., LG Energy Solution Ltd., NEC Corporation, The General Electric Company, Jabil, Inc.
